N/A
N=77
Psychosis Screening in Juvenile Justice
Psychotic Disorders · Psychosis Nos/Other
Bottom Line
View on ClinicalTrials.gov: NCT03583073 ↗Enrolled (actual)
77
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Number of Participants Who Used Outpatient Mental Health Services — 20; 9 Participants — p=.053
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Enhanced Referral/Linkage to Care (Behavioral); Standard Care (Behavioral)
- Age
- Pediatric · 12+ yrs
- Sex
- All
- Sponsor
- Brown University
- Primary completion
- Jan 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Used Outpatient Mental Health Services |
20; 9 | .053 |
| SECONDARY Psychosis-spectrum Positive Symptoms |
5.89; 3.95 | .072 |
Summary
This study will investigate the occurrence of psychosis-spectrum disorders among youth in the Juvenile Justice System and track mental health referrals for these youth in Phase 1, a standard care condition. Then, in Phase 2, an enhanced referral and linkage to care model will be employed, with the aim of bolstering motivation for and engagement in mental health treatment. It is hypothesized that the enhanced referral protocol will promote completion of mental health care referrals.
Eligibility Criteria
Inclusion Criteria
- Adolescent being seen in the Juvenile Justice System
- Legal guardian available to consent for juvenile's participation
- Adolescent assents to participate
- Adolescent is English speaking
- Parent/guardian may be English or Spanish-speaking
- Adolescent flags positive on the MAYSI-2 Thought Disturbance subscale or the PQ-B
Exclusion Criteria
- Adolescent has observable developmental delays that would interfere with obtaining assent and/or accurate assessment
- Adolescent meets hospital level of care for imminent risk due to severity of symptoms
Data sourced from ClinicalTrials.gov (NCT03583073). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.